Skip to main content

Elutia Inc.

ELUT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001708527

No open-market purchases or sales by Elutia Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $17.0M in total; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, +4 vs. previous quarter
39
13F valueReported value at the end of Q2 2026
$17.0M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding ELUT, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding ELUT at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Elutia Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 2, 2026 (view filing)5:01 PM ETJan 303 daysRakin Kevin and 3 othersDirector, 10% OwnerPPurchaseClass A Common Stock+70.0K$1.06+$74.2K+55.5%196.1K after
Feb 2, 2026 (view filing)Jan 303 daysNeels Guido JDirectorPPurchaseClass A Common Stock+20.0K$1.04+$20.8K+20.3%118.8K after
Jan 29, 2026 (view filing)Jan 28-291 dayNeels Guido JDirectorPPurchaseClass A Common Stock+30.0K$1.06+$31.8K+43.6%98.8K after2 lots
Dec 19, 2025 (view filing)4:59 PM ETDec 172 daysRakin Kevin and 3 othersDirector, 10% OwnerPPurchaseClass A Common Stock+50.0K$0.5199+$26.0K+18.4%322.4K after
Dec 18, 2025 (view filing)Dec 171 dayColpman DavidDirectorPPurchaseClass A Common Stock+12.5K$0.51+$6.38K+67.2%31.1K after
Dec 18, 2025 (view filing)Dec 171 dayMakes BrigidDirectorPPurchaseClass A Common Stock+25.0K$0.52+$13.0K+1,250.0%27.0K after
Dec 18, 2025 (view filing)Dec 171 dayMills C RandalPRESIDENT AND CEOPPurchaseClass A Common Stock+3.00K$0.51+$1.53K+0.8%379.2K after
Dec 18, 2025 (view filing)Dec 171 dayFerguson MatthewCHIEF FINANCIAL OFFICERPPurchaseClass A Common Stock+60.0K$0.53+$31.8K+15.5%447.1K after
Dec 3, 2025 (view filing)Dec 1-22 daysFerguson MatthewCHIEF FINANCIAL OFFICERPPurchaseClass A Common Stock+10.0K$0.661+$6.61K+2.7%379.1K after2 lots
Nov 26, 2025 (view filing)Nov 242 daysMills C RandalPRESIDENT AND CEOPPurchaseClass A Common Stock+5.00K$0.60+$3.00K+1.4%358.8K after

Top 10 13F holders, Q2 2026

The largest institutional positions in Elutia Inc. at the end of Q2 2026; share changes are against Q1 2026.

See all 39 holders
Institutions holding ELUT in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Nantahala Capital Management, LLC6,369,894$6.24M0.19%+3,184,947+100.0%Added
AIGH Capital Management LLC2,695,644$2.64M0.24%−899,606−25.0%Reduced
Knollwood Investment Advisory, LLC2,556,724$2.50M0.22%00.0%Unchanged
Silverarc Capital Management, LLC2,192,980$2.15M0.24%−305,040−12.2%Reduced
Vanguard Capital Management LLC1,142,575$1.12M0.00%+118,876+11.6%Added
Perkins Capital Management Inc694,094$379.9K0.29%−62,800−8.3%Reduced
Geode Capital Management, LLC285,229$279.4K0.00%−8,167−2.8%Reduced
CI Private Wealth, LLC253,500$248.3K0.00%+4,468+1.8%Added
Renaissance Technologies LLC201,816$197.7K0.00%+119,100+144.0%Added
Vanguard Fiduciary Trust Co172,446$169.0K0.00%+53,101+44.5%Added